Not All Types of Atrial Fibrillation Carry the Same Stroke Risk, but Most Benefit From Oral Anticoagulation

Circulation: Arrhythmia and Electrophysiology - United States
doi 10.1161/circep.116.004847
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Oral Anticoagulation to Reduce Risk of Stroke in Patients With Atrial Fibrillation: Current and Future Therapies

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2013English

Recent Advances in Oral Anticoagulation for Atrial Fibrillation

Therapeutic Advances in Cardiovascular Disease
Cardiovascular MedicinePharmacologyCardiology
2010English

Subclinical Atrial Fibrillation and the Risk of Stroke

New England Journal of Medicine
Medicine
2012English

Risk of Ischemic Stroke in Thyrotoxic Atrial Fibrillation

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Paroxysmal Atrial Fibrillation, Stroke Risk and Thromboprophylaxis

Thrombosis and Haemostasis
Hematology
2008English

Efficacy and Safety of Oral Anticoagulation in Elderly Patients With Atrial Fibrillation

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2018English

Left Atrial Effective Conducting Size Predicts Atrial Fibrillation Vulnerability in Persistent but Not Paroxysmal Atrial Fibrillation

Journal of Cardiovascular Electrophysiology
Cardiovascular MedicinePhysiologyCardiology
2019English

Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2019English

Atrial Fibrillation Genetic Risk and Ischemic Stroke Mechanisms

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy